Business Segments SurModics
Stocks
SRDX
US8688731004
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
02:30:00 19/11/2025 am IST
|
5-day change | 1st Jan Change | ||
| 42.98 USD | +0.35% |
|
-.--% | - |
| 19/05 | Endologix LLC acquired Pounce? Thrombectomy System from Surmodics, Inc. | CI |
| 10/12 | Surmodics, Inc. acquired certain assets from Biocoat, Incorporated. | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Medical Device | 7.14Cr | 7.83Cr | 7.24Cr | 11Cr | 9.75Cr | |||||
D&A | 62.23L | 72.24L | 83.68L | 78.74L | 79.01L | |||||
Operating Income | -32.46L | 46.83L | -2.29Cr | 50.84L | -22.39L | |||||
In Vivo Diagnostic Substances | ||||||||||
In Vitro Diagnostics | 2.35Cr | 2.69Cr | 2.76Cr | 2.68Cr | 2.86Cr | |||||
D&A | 5L | 4L | 4L | 3L | 4L | |||||
Operating Income | 1.18Cr | 1.38Cr | 1.31Cr | 1.26Cr | 1.31Cr | |||||
Operating Income | -97.76L | -1.18Cr | -1.22Cr | -1.26Cr | -1.65Cr | |||||
D&A | 6L | 4L | 4L | 3L | 4L |
| Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 7.4Cr | 8.31Cr | 7.4Cr | 11Cr | 10Cr | |||||
Total Assets | 2.53Cr | 2.59Cr | 2.48Cr | 2.35Cr | 2.23Cr | |||||
Foreign | 2.09Cr | 2.21Cr | 2.6Cr | 2.39Cr | 2.14Cr | |||||
Total Assets | 1.81Cr | 4.12Cr | 3.05Cr | 2.87Cr | 2.62Cr |
- Stock Market
- Stocks
- SRDX Stock
- Financials SurModics
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
